Biofrontera (BFRI) Gross Profit Growth (3y) (2023 - 2025)
Biofrontera (BFRI) Gross Profit Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 0.95% |
| 10 | Biofrontera | 10.73 Mn | 4.32 Mn | 14.09 Mn | 57.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.70% |
| Sep 30, 2025 | 5.38% |
| Jun 30, 2025 | 14.06% |
| Mar 31, 2025 | -17.79% |
| Dec 31, 2024 | 35.43% |
| Sep 30, 2024 | -1.24% |
| Jun 30, 2024 | -15.13% |
| Mar 31, 2024 | -6.07% |
| Sep 30, 2023 | 46.38% |